Company / Accounts Receivable
LifeStance Health Group, Inc. Accounts Receivable History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$95.7M
FY2025
5-year range
$76.1M / $131.8M
FY2021-FY2025
Trend
-27.4%
vs FY2024
Sector context
#99 of 143
Health Care
What the data says
At $96M, LifeStance Health Group, Inc.'s accounts receivable ranks #99 of 143 in the Health Care sector. Declined from $125M to $96M over the past 2 years.
Based on SEC 10-K filings.
$96M in FY2025 with a 5-year CAGR of +17.0%.
Declined from $125M to $96M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -1.7%
- 5-Year CAGR
- +17.0%
- 10-Year CAGR
- -
Sector benchmark
#99 of 143 in Health CareTop 69% of 143This company $95.7M Sector average $1.3B
▼
-92.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.0%, indicating consistent growth.
- In FY2025, accounts receivable decreased 27.4% year-over-year.
- Ranks #99 out of 143 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $95.7M | -27.4% |
| FY2024 | $131.8M | +5.1% |
| FY2023 | $125.4M | +24.3% |
| FY2022 | $100.9M | +32.6% |
| FY2021 | $76.1M | +74.1% |
| FY2020 | $43.7M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026